Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
Mirum Pharmaceuticals
MIRM
$5.28B
| $19.4M | ﹤0.01% |
925,177
+495,330
| +115% | +$11.9M |
2021 Q3
4 quarters
|
|
1852
PUT
Franco-Nevada
FNV
$46.4B
| $19.4M | ﹤0.01% |
162,500
+27,700
| +21% | +$3.48M |
2013 Q3
36 quarters
|
|
1853
PUT
Scotiabank
BNS
$107B
| $19.4M | ﹤0.01% |
407,400
+153,200
| +60% | +$8.76M |
2013 Q2
37 quarters
|
|
1854
Sony
SONY
$140B
| $19.3M | ﹤0.01% |
1,510,280
+495,410
| +49% | +$7.94M |
2016 Q4
23 quarters
|
|
|
CPUH
1855
DELISTED
Compute Health Acquisition Corp.
CPUH
| $19.3M | ﹤0.01% |
1,955,483
-328
| -0% | -$3.23K |
2021 Q1
6 quarters
|
|
1856
DoubleVerify
DV
$2.11B
| $19.3M | ﹤0.01% |
705,513
-308,394
| -30% | -$7.95M |
2021 Q4
3 quarters
|
|
1857
Analog Devices
ADI
$197B
| $19.3M | ﹤0.01% |
138,353
-182,741
| -57% | -$28.9M |
2020 Q1
10 quarters
|
|
|
GRMN
1858
PUT
Garmin
GRMN
$51.8B
| $19.3M | ﹤0.01% |
240,000
+94,600
| +65% | +$8.94M |
2013 Q2
37 quarters
|
|
1859
PUT
Kinder Morgan
KMI
$71.8B
| $19.3M | ﹤0.01% |
1,157,000
+323,300
| +39% | +$5.75M |
2013 Q2
37 quarters
|
|
1860
CALL
Atkore
ATKR
$3.2B
| $19.2M | ﹤0.01% |
247,200
+73,400
| +42% | +$6.35M |
2020 Q4
7 quarters
|
|
1861
PTC Therapeutics
PTCT
$5.22B
| $19.2M | ﹤0.01% |
382,985
+306,990
| +404% | +$15M |
2017 Q4
19 quarters
|
|
1862
Air Products & Chemicals
APD
$62B
| $19.2M | ﹤0.01% |
82,507
-15,464
| -16% | -$3.83M |
2013 Q2
37 quarters
|
|
1863
PUT
WIX.com
WIX
$3.1B
| $19.2M | ﹤0.01% |
245,000
+153,500
| +168% | +$10.6M |
2017 Q1
22 quarters
|
|
1864
Tenet Healthcare
THC
$21B
| $19.2M | ﹤0.01% |
371,545
-1,253,542
| -77% | -$74.4M |
2013 Q2
37 quarters
|
|
1865
CALL
Corning
GLW
$132B
| $19.2M | ﹤0.01% |
660,300
-61,000
| -8% | -$2.07M |
2013 Q2
37 quarters
|
|
1866
PUT
Lamar Advertising Co
LAMR
$14.8B
| $19.2M | ﹤0.01% |
232,300
+196,500
| +549% | +$18.7M |
2013 Q2
37 quarters
|
|
1867
Fulton Financial
FULT
$4.25B
| $19.2M | ﹤0.01% |
1,212,435
-285,869
| -19% | -$4.61M |
2016 Q2
25 quarters
|
|
1868
CALL
AB InBev
BUD
$152B
| $19.1M | ﹤0.01% |
423,500
-10,300
| -2% | -$533K |
2016 Q2
25 quarters
|
|
1869
PUT
Robinhood
HOOD
$96.2B
| $19.1M | ﹤0.01% |
1,892,600
-1,516,200
| -44% | -$14.6M |
2021 Q3
4 quarters
|
|
1870
Castle Biosciences
CSTL
$1.03B
| $19.1M | ﹤0.01% |
732,655
+102,059
| +16% | +$2.86M |
2020 Q2
9 quarters
|
|
|
FOLD
1871
DELISTED
Amicus Therapeutics
FOLD
| $19.1M | ﹤0.01% |
1,828,459
-1,899,081
| -51% | -$21.2M |
2018 Q3
16 quarters
|
|
1872
CALL
ARK Genomic Revolution ETF
ARKG
$2.02B
| $19.1M | ﹤0.01% |
580,000
-75,000
| -11% | -$2.75M |
2020 Q3
8 quarters
|
|
1873
Booz Allen Hamilton
BAH
$8.77B
| $19M | ﹤0.01% |
206,257
-48,856
| -19% | -$4.63M |
2022 Q1
2 quarters
|
|
|
1874
CALL
Tenet Healthcare
THC
$21B
| $19M | ﹤0.01% |
368,900
+253,900
| +221% | +$15.1M |
2013 Q2
37 quarters
|
|
|
KRTX
1875
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $19M | ﹤0.01% |
84,500
-400
| -0.5% | -$81K |
2020 Q1
10 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.